Article
Berberine ameliorates atherosclerosis by inhibiting the phenotypic transition of vascular smooth muscle cells via suppression of the JAK2/STAT3 signaling pathway.
European journal of pharmacology - 15 Nov 2025
Zheng Junmeng, Wang Tingting, Zhou Yang, Chen Yushan, Shen Xiangli, Jin Boyuan, Han Xinyi, Hua Chengjun, Xie JinHong
Abstract excerpt
Atherosclerosis (AS) is a widespread cardiovascular disease that significantly impacts human health. This study aimed to investigate the anti-atherosclerotic effects of berberine (BBR) and elucidate its mechanisms through animal and cellular experiments. Apolipoprotein E-deficient (ApoE-/-) mice were fed a high-fat diet for 12 weeks to induce AS. The mice were subjected to the corresponding interventions for 4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
